转移性癌症患者的死亡原因
Kyle Mani1,2, Daxuan Deng3, Christine Lin4,2
1Albert Einstein School of Medicine, Bronx, NY, USA.
Nature communications
|February 20, 2024
概括
大多数转移性癌症患者死于癌症,但有些人死于其他原因,如心脏病. 风险因癌症类型而异,肺癌和胰腺癌的死亡风险更高.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 生物统计学 生物统计学
背景情况:
- 了解转移性癌症的死亡率对于患者护理和资源配置至关重要.
- 相互竞争的死亡原因对癌症患者的生存统计数据产生了重大影响.
研究的目的:
- 分析大量转移性癌症患者的死亡原因.
- 为了确定癌症类型与较高的死亡风险从原发性癌症与竞争原因.
- 预测被诊断为癌症的死亡风险与其他原因.
主要方法:
- 分析了一大批美国数据集 (1992-2019) 超过100万转移性癌症幸存者的数据集.
- 对13种癌症类型和25种非癌症疾病的死亡原因的描述.
- 应用精细和灰色竞争风险模型来预测生存率.
主要成果:
- 82.6%的患者死于他们诊断的转移性癌症;17.4%死于竞争性原因.
- 肺癌,胰腺癌,食道癌和胃癌是死于癌症的最高可能性.
- 前列腺癌和乳腺癌是癌症死亡的可能性最低的.
- 主要的非癌症死亡原因包括心脏病 (32.4%),COPD (7.9%) 和中风 (6.1%).
结论:
- 虽然被诊断出癌症是大多数转移性患者的主要死亡原因,但竞争性原因很重要.
- 癌症类型强烈地影响了因主要疾病而死亡的可能性,而不是其他疾病.
- 准确的风险预测模型对于理解和管理晚期癌症死亡率至关重要.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


